Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-12-12 22:57 CET (UTC+1h)
 

Exploratory pilot studies without filing IND [Regulatives / Guidelines]

posted by jag009 - NJ, 2017-10-02 16:12  - Posting: # 17844
Views: 485

Hi,

Anyone has experience running pilot PK studies without filing an IND in USA?

Specifically, running a pilot study that compares a test product against a reference with the test product having a slight higher dose than the reference given at the maximum total daily dose. The test is designed to have the similar bioavailability(AUC) as the reference and a slower release rate(lower Cmax with longer Tmax).

I don't think it's possible because there is no in-vivo data. I don't think dissolution data alone + info from reference's original NDA about having studies conducted at higher doses would be sufficient. If the test and reference are under the same total daily dose then yes.

Thanks
J

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,555 Posts in 3,758 Threads, 1,089 registered users;
33 users online (0 registered, 33 guests).

Enlightenment is man’s emergence from his self-imposed nonage
for which he himself was responsible.
Nonage is the inability to use one’s own intellect
without the direction of another.    Immanuel Kant

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed